Poster: Advanced Therapies London 2025

Controlling cell-to-cell adhesion to facilitate process optimisation and intensification

As presented by our Head of Technology at Advanced Therapies London in 2025, this poster provides an overview of the transformative benefits of AggreGuard on microcarrier-based cultures.

Related Blogs

Except for hematopoietic-derived cells, most cells isolated from animals are naturally adherent. In vivo, adherent cells interact with their surrounding environment and …

Multiple industries struggle to scale adherent cell culture for applications where the cells themselves are the target product. Traditional methods like T-flasks …

CellRev launches its proprietary media additive AggreGuard™ which prevents aggregation of adherent cells and increases cell yield in existing VERO processes CellRev, …

Share